Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;65(Supplement):S14-S23.
doi: 10.4103/ijpm.ijpm_34_22.

A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted

Vani Santosh  1 , Shilpa Rao  1
Affiliations
Free article
Review

A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted

Vani Santosh et al. Indian J Pathol Microbiol. 2022 May.
Free article

Abstract

The fifth edition of the World Health Organization (WHO) Classification of Tumors of the Central Nervous System (WHO CNS5) features several changes in the classification, diagnostic criteria, nomenclature, and grading of diffuse gliomas. Adult-type diffuse gliomas are genetically defined and include astrocytoma, isocitrate dehydrogenase (IDH)-mutant, oligodendroglioma, IDH-mutant and 1p/19q codeleted, and glioblastoma, IDH-wildtype. This review briefly discusses two tumor types: astrocytoma, IDH-mutant, and oligodendroglioma, IDH-mutant and 1p/19q codeleted, with emphasis on relevant changes in their classification and defining molecular genetic alterations. A simplified approach to the diagnosis of these tumors is provided.

Keywords: Adult-type; WHO CNS5 classification; diffuse gliomas.

PubMed Disclaimer

Conflict of interest statement

None

Similar articles

See all similar articles

Cited by

  • Aggressiveness of Grade 4 Gliomas of Adults.
    Deacu M, Docu Axelerad A, Popescu S, Topliceanu TS, Aschie M, Bosoteanu M, Cozaru GC, Cretu AM, Voda RI, Orasanu CI. Deacu M, et al. Clin Pract. 2022 Sep 3;12(5):701-713. doi: 10.3390/clinpract12050073. Clin Pract. 2022. PMID: 36136867 Free PMC article.

Substances

LinkOut - more resources